Neuronetics Inc. (STIM) Stock: Dividends & Earnings

Company Overview:

Market Cap: $167.00M

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $0.80 - $3.44

8.3 Year STIM Performance Metrics:

Total Return (with DRIP): -91.6% (-25.78% CAGR)

Total Return (no DRIP): -91.6% (-25.78% CAGR)

Share Price: -91.6% (-25.78% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $842

Total Return $ (with DRIP): -$9,158

STIM Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

STIM Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for STIM

Based on past 8.3-year performance, here are STIM growth metrics:

Share price CAGR of -25.78%
Dividend CAGR of +0%

Using STIM CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	STIM (DRIP)	STIM - No DRIP
Current Price	$2.34	$2.34
Start Shares	4,273.50	4,273.50
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	4,273.50	4,273.50
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.12	$2.34
Total Dividends	$0	$0
Final Value	$507	$10,000

Estimated Future Value + Dividends - STIM

NOTE: Above numbers are our estimate based on STIM's Dividend and Price CAGR over past 8.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Neuronetics Inc. (STIM) had its IPO on , and is traded on NASDAQ stock exchange.

Neuronetics Inc. is a commercial-stage medical technology company focused on non-invasive neurohealth treatments. Its core offering is the NeuroStar Advanced Therapy System, an office-based transcranial magnetic stimulation platform used primarily for adult patients with major depressive disorder. The company also provides related treatment sessions and support services, serving psychiatric practices and mental health providers in the United States and international markets. Neuronetics operates at the intersection of medical devices and clinic services, combining device commercialization with patient care delivery. Its products are designed to expand access to non-drug therapeutic options for psychiatric and neurological conditions, making the company a significant participant in the neuromodulation market.

STIM website: https://neurostar.com/neuronetics